Patents by Inventor Christine D. Eberhardt

Christine D. Eberhardt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Platelet-activating factor acetylhydrolase
    Publication number: 20030072747
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Application
    Filed: October 13, 2001
    Publication date: April 17, 2003
    Applicant: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Publication number: 20010021379
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Application
    Filed: December 4, 2000
    Publication date: September 13, 2001
    Applicant: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 6203790
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: March 20, 2001
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 6146625
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: January 22, 1998
    Date of Patent: November 14, 2000
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase (PAF-AH) therapeutic uses
    Patent number: 6099836
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events. Specifically disclosed are methods for the treatment of reperfusion injury using platelet-activating factor acetylhydrolase products.
    Type: Grant
    Filed: June 19, 1998
    Date of Patent: August 8, 2000
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 6045794
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: June 9, 1999
    Date of Patent: April 4, 2000
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 5977308
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: August 12, 1997
    Date of Patent: November 2, 1999
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Antibodies specific for platelet-activating factor acetylhydrolase
    Patent number: 5847088
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 8, 1998
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Methods of detecting platelet-activating factor acetylhydrolase using antibodies
    Patent number: 5698403
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 16, 1997
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 5656431
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: August 12, 1997
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 5641669
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: June 24, 1997
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai Le Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Methods of detecting lesions in the platelet-activating factor acetylhydrolase gene
    Patent number: 5605801
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events. Furthermore provided are therapeutic and diagnostic methods using such polynucleotide sequences and platelet-activating factor acethylhydrolase products.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 25, 1997
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Hai L. Trong, Larry W. Tjoelker, Cheryl L. Wilder
  • Platelet-activating factor acetylhydrolase
    Patent number: 5532152
    Abstract: The present invention provides purified and isolated polynucleotide sequences encoding human plasma platelet-activating factor acetylhydrolase. Also provided are materials and methods for the recombinant production of platelet-activating factor acetylhydrolase products which are expected to be useful in regulating pathological inflammatory events.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: July 2, 1996
    Assignee: ICOS Corporation
    Inventors: Lawrence S. Cousens, Christine D. Eberhardt, Patrick Gray, Larry W. Tjoelker, Cheryl L. Wilder, Hai Trong